Simplex Trading’s Trillium Therapeutics Inc. TRIL Stock Holding History

Simplex Trading’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-92,500	Closed	-$914K	–	11968
2021 Q3	$914K	Hold	92,500	–	–	﹤0.01%	3201
2021 Q2	$897K	Buy	92,500 +91,274	+7,445%	+$859K	﹤0.01%	3278
2021 Q1	$1.32M	Buy	+1,226	New	+$15.2K	﹤0.01%	2099
2020 Q4	–	Sell	-1,312	Closed	-$1.86M	–	9394
2020 Q3	$1.86M	Buy	+1,312	New	+$13.1K	﹤0.01%	1607
2020 Q2	–	Sell	-384	Closed	-$155K	–	8697
2020 Q1	$155K	Buy	384 +360	+1,500%	+$1.36K	﹤0.01%	3886
2019 Q4	$2K	Buy	+24	New	+$9	﹤0.01%	7027
2018 Q1	–	Sell	-60	Closed	-$5K	–	7168
2017 Q4	$5K	Buy	+60	New	+$497	﹤0.01%	4598

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Simplex Trading's TRIL Position: Q2 2021 in Review

Simplex Trading sold out of Trillium Therapeutics Inc. (TRIL) in Q2 2021, closing a stake of 41,948 shares — an estimated $395K sold.

Simplex Trading first reported a position in TRIL in Q2 2018 and held it in 5 quarters. The position peaked at $450K in Q1 2021. 137 funds tracked by Wall St. Rank hold TRIL as of Q2 2021.

Simplex Trading reported no remaining Trillium Therapeutics Inc. position as of Q2 2021 after selling out during the quarter.
Simplex Trading sold 41,948 Trillium Therapeutics Inc. shares in Q2 2021, an estimated $395K.
Simplex Trading first reported a position in Trillium Therapeutics Inc. in Q2 2018 and held it in 5 quarters.
Simplex Trading's Trillium Therapeutics Inc. position peaked at $450K in Q1 2021.
137 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q2 2021.

Based on Simplex Trading's 13F filing for Q2 2021, filed 12 Aug 2021.